# Top 50 Medical Angel Investors in United Kingdom in June 2026

## Jonathan Milner
- Type: Angel
- Location: Cambridge, Massachusetts, United States
- Relevant deals: 12
- Stages: Seed, Series A, Series B
- Focus: Biotechnology, Health Care, Medical

Having worked in the life sciences industry for over ten years as an academic researcher, Jonathan identified the market opportunity for supplying high quality antibodies to support protein interaction studies and, in 1998, founded Abcam with David Cleevely and Professor Tony Kouzarides. Jonathan is a Non-Executive Director of Horizon DiscoveryGroup plc, The Evolution Education Trust, GeoSpock Ltd and Sydicate Room Group Ltd. He is also Chairman of Axol Bioscience Ltd, PhoreMost Ltd, Repositive Limited, Definigen Limited and Cambridge Allergy Ltd. Jonathan holds an executive director position at Meltwind Limited, being a designated member of Meltwind Advisory LLP. Jonathan is an experienced entrepreneur and investor and is passionate about supporting UK life science and high-tech start-ups. He has provided considerable investment and support to over 30 companies and has assisted three AIM IPOs.

## Ian Hogarth
- Type: Angel
- Location: London, England, United Kingdom
- Relevant deals: 3
- Stages: Seed, Series A, Pre-Seed
- Focus: Software, E-Commerce, Artificial Intelligence

Ian Hogarth is based out of London, England, and is the Chairman of Phasecraft. Ian previously worked at Songkick as a Chairman. Ian Hogarth attended the University of Cambridge.

## Matt Robinson
- Type: Angel
- Location: London, England, United Kingdom
- Relevant deals: 2
- Stages: Seed, Series A, Pre-Seed
- Focus: Software, FinTech, Financial Services

Matt Robinson is the CEO and a co-founder at Nested, a property technology company. Prior to this, he founded GoCardless in 2010 and remains on the board of the recurring payment company.

## Michael Pennington
- Type: Angel
- Location: London, England, United Kingdom
- Relevant deals: 2
- Stages: Seed, Pre-Seed
- Focus: Software, SaaS, FinTech

One of the UK's leading tech angel investors. Active seed and pre-seed stage angel investor in UK based disruptive tech. Prefers businesses venturing into pastures new and keen investing at the pre product stage whether BtoC or B2B.
Twice exited UK based tech entrepreneur with experience operating tech businesses in 20 countries in multiplelanguages. Co-founded Gumtree with Simon Crookall which was acquired by Ebay and Slando acquired by Naspers.

## Will Brooks
- Type: Angel
- Location: London, England, United Kingdom
- Relevant deals: 2
- Stages: Seed, Series A
- Focus: FinTech, Financial Services, Software

Will Brooks - Founder & Director @ Portfolio Ventures

## Taavet Hinrikus
- Type: Angel
- Location: London, England, United Kingdom
- Relevant deals: 2
- Stages: Seed, Series A, Series B
- Focus: FinTech, Software, Financial Services

Taavet Hinrikus is based out of London, England and is the Partner of Plural Platform and Board Member of CoMind. Taavet previously worked at Wise as a Chairman and Co-founder. Taavet Hinrikus attended INSEAD.

## Will Martin
- Type: Angel
- Location: London, England, United Kingdom
- Relevant deals: 2
- Stages: Seed, Series A
- Focus: Financial Services, Software, FinTech

Will Martin - Founder and Director @ Portfolio Ventures

## Mark Bamforth
- Type: Angel
- Location: Boston, Massachusetts, United States
- Relevant deals: 2
- Stages: Series A, Seed
- Focus: Health Care, Medical, Biotechnology

Mark Robert Bamforth is based out of Boston, Massachusetts and is the Chief Executive Officer of disAMR and Executive Advisor of Ampersand Capital Partners. Mark previously worked at Kincell Bio as a Chief Executive Officer. Mark Robert Bamforth attended the Henley Business School.

## Ariel Poler
- Type: Angel
- Location: San Francisco, California, United States
- Relevant deals: 2
- Stages: Seed, Series A, Angel
- Focus: Software, Social Media, Internet

Ariel Poler is the Co-Founder of Reveri Health. Ariel is an Internet entrepreneur, mentor, and investor. He was the founder of IPRO, the first web analytics company, and of Topica, one of the first email communities. Ariel was a board member of Kana Software, LinkExchange, Odeo, LOLapps, and StumbleUpon. He currently serves on the boards of FreedomFinancial Network, MixTent, Strava, and Scan Inc. Ariel’s angel investments include AdMob, Flixster, Slideshare, Xobni, RockYou, and Outright, BrightRoll, Instructables, Causes, Kongregate and NexTag. Ariel holds a B.S. in Mathematics with Computer Science from MIT and an MBA from Stanford University. He is originally from Venezuela and lives in San Francisco with his wife and three children.

## Alexander Chesterman
- Type: Angel
- Location: London, England, United Kingdom
- Relevant deals: 2
- Stages: Seed, Pre-Seed, Series A
- Focus: FinTech, E-Commerce, Financial Services

Alex Chesterman is the Co-Founder of Houseful. Alex Chesterman attended the University College London.

## Matt Clifford
- Type: Angel
- Location: London, England, United Kingdom
- Relevant deals: 2
- Stages: Seed, Pre-Seed
- Focus: Software, FinTech, Artificial Intelligence

Matt co-founded EF after being a consultant at McKinsey & Co. Prior to EF Matt spent his time studying at MIT fuelled by an obsession with R, Python and unusual datasets. EF is the best place for Europe’s top technical individuals to meet and build world-changing startups in London.They select purely on the basis of technical talent, so youcan apply before you have a team or an idea. The intensive 6-month programme is designed to give you the best possible support in the first 200 days of your startup’s life.They have created over 40 startups now worth over $300 million. The startups are funded by some prestigious investors including Balderton Capital, Index Ventures, Octopus Investments and Y Combinator.

## Errol Damelin
- Type: Angel
- Location: London, England, United Kingdom
- Relevant deals: 1
- Stages: Seed, Series A, Pre-Seed
- Focus: FinTech, Financial Services, Finance

Errol Damelin is the Founder, CEO, chairman, or original investor and backer of over 75 digital and tech companies around the world, including in the US, the UK, most of Europe, Israel, Indonesia, Brazil, Turkey, South Africa, and Nigeria. He concentrates his efforts on SaaS, fintech, crypto, marketplaces and data analytics as well as on health andwellness. He is also a technologist and has three granted patents to his name with another four pending.Among the companies co-founded by Damelin are groundbreaking fintech company Wonga, and SME banking startup Tide. His early investments include Wise, Cazoo, Purplebricks, K Health, YuLife, Sure, Demyst, Zoe, Farewill, CityMapper, Modifi, UnBabel, Thimble, HiBob, Modifi, Elliptic, Lendingkart, and VivaReal. 
Using his own personal equity, Damelin continues to invest early on in the next generation of entrepreneurs so that he can help them succeed. He is not an institutional VC fund and does not maximize the assets under his management. He best describes his approach as Riding Shotgun.Damelin's success as a founder has been recognized by The Guardian, which named him Digital Entrepreneur of the Year in 2011; by Ernst and Young, which named him the UK's Entrepreneur of the Year in 2011 as well; and by TechCrunch, which named him Founder of the Year in 2010.

## Bob Davis
- Type: Angel
- Location: Cambridge, Massachusetts, United States
- Relevant deals: 1
- Stages: Series A, Series B, Series C
- Focus: Internet, Advertising, Social Network

Bob Davis is a General Partner at Highland Capital Partners and an Executive Chairman at Highland Transcend Partners. He was a CEO at Lycos. Bob attended Northeastern University and Babson College.

## Thomas Dyrberg
- Type: Angel
- Relevant deals: 1
- Stages: Series B, Series C, Seed
- Focus: Biotechnology, Medical, Health Care

Thomas P. Dyrberg, M.D., Ph.D., serves as Senior Partner of Novo Ventures and Novo A/S. Thomas Dyrberg joined Novo A/S in December 2000, where he was a Partner.He held research positions at the Hagedorn Research Institute, Gentofte, Denmark and at the Scripps Research Institute, La Jolla, California.In 1990, he joined Novo NordiskA/S and worked in health care discovery on various aspects of diabetes immunology and pathogenesis and health Care Clinical Drug Development as an International Clinical Project Manager since 1996. He serves as the Deputy Chairman of Veloxis Pharmaceuticals A/S and has been its Director since September 2003.Thomas Dyrberg has been a Director at Gloucester Pharmaceuticals, Inc. since August 25, 2009. He serves as a Director at Rejuvenon, Corp, Allocure Inc., Veloxis, Lux Biosciences, Inc., Ophthotech Corporation, Sapphire Therapeutics Inc., and Delenex Therapeutics AG.He served as a Director of BioMimetic Therapeutics, Inc. from May 2001 to June 21, 2007. He served as a Director of Helsinn Therapeutics (U.S.), Inc. He has published several articles within the fields of diabetes, immunology, and autoimmunity.Thomas Dyrberg has an M.D. degree in 1981 and his DM.Sc. degree from the University of Copenhagen in 1986.

## Flavien Kulawik
- Type: Angel
- Location: London, England, United Kingdom
- Relevant deals: 1
- Stages: Seed, Series A
- Focus: Health Care, Artificial Intelligence, SaaS

Flavien Kulawik

## Pa Nolan
- Type: Angel
- Relevant deals: 1
- Stages: Seed
- Focus: Medical, Delivery, Shipping

Pa Nolan

## Arthur Chen
- Type: Angel
- Location: London, England, United Kingdom
- Relevant deals: 1
- Stages: Seed, Series A
- Focus: Medical, Chemical, Software

Arthur Chen is a Managing Partner at Ameba Capital.

## Emilio Püschmann
- Type: Angel
- Location: Bogotá, Distrito Especial, Colombia
- Relevant deals: 1
- Stages: Pre-Seed
- Focus: Medical, Database, Consulting

Emilio Püschmann

## Nicolaus Henke
- Type: Angel
- Location: London, England, United Kingdom
- Relevant deals: 1
- Stages: Seed, Pre-Seed
- Focus: Information Technology, SaaS, Medical

Nicolaus Henke is a senior partner at McKinsey & Company, where he advises leading companies on how to improve decision making and performance through advanced analytics, artificial intelligence, and end-to-end data enabled transformations, and is the global leader of McKinsey Analytics, which has more than 2,000 dedicated analyticspractitioners and translators, where he oversees partnerships between McKinsey and the wider artificial intelligence, data, and computing ecosystem. Nicolaus is the chairman of QuantumBlack (acquired by McKinsey in 2015), a company operating at the intersection of strategy, technology, and design, and a member of McKinsey’s global board, the Shareholder’s Council. He helped found and is a member of the Board of Innovative Healthcare Delivery at Duke Medicine and serves on the Dean’s Advisory Council at Harvard’s Kennedy School. Nicolaus frequently speaks on big data, analytics, and healthcare topics at global forums such as the World Economic Forum, the Milken Institute, and Forbes. He holds a master’s degree and PhD in business from the University of Münster, Germany, and a master’s in public administration from Harvard University, where he was a John J. McCloy Scholar.

## John Taysom
- Type: Angel
- Location: London, England, United Kingdom
- Relevant deals: 1
- Stages: Seed, Angel, Series A
- Focus: Software, Information Technology, Artificial Intelligence

John Taysom started the Reuters Venture Capital Fund in Palo Alto in 1995 making 82 investments in internet and web infrastructure and services including Verisign, UltraDNS, Digimarc, ZeroKnowledge and Intertrust. He was a member of the Board of Digimarc pre and post its Nasdaq IPO, a Board member at Intertrust and a Board member at TIBCO throughits Nasdaq IPO. To date, seventeen of his investments have achieved an IPO.John acquired the Fund in an MBO in 2002. Now London-based with a seed portfolio of thirty US and UK start-ups; one has achieved an IPO and several have been acquired by Experian, Linkedin, Tesco, BMC and others.In 2011 and 2012 John took a Fellowship at Harvard to work on privacy issues and holds EU and US patents on a method of improving privacy online. For 2015 John is a Policy Fellow at the University of Cambridge Centre for Science and Policy and a Visiting Professor, Department of Computer Science, at UCL. He is a member of the Board of the Web Science Trust; chairs Performance Horizon, a fast growing UK startup; is a Governor at Hurstpierpoint College; and runs a small farm in Devon.

## Peer Schatz
- Type: Angel
- Location: Düsseldorf, Nordrhein-Westfalen, Germany
- Relevant deals: 1
- Stages: Seed
- Focus: Medical, Genetics, Health Care

1989, Master's in Finance, Univ. of St Gallen, Switzerland; 1991, MBA in Finance, Graduate School of Business, Univ. of Chicago. Former: Partner, private management buy-out group, Switzerland; finance and systems positions, Sandoz and Computerland; finance, operations, management and sales positions, computer and software trading start-upcompanies, Europe, US. 1993, joined QIAGEN, when the company had just 30 employees and revenues of approximately $2 million. Former Member, German Corporate Governance Commission. Director: AdvaMedDx (US in-vitro diagnostics industry organization); ALDA (Analytical, Life Science & Diagnostics Association).

## Will Armitage
- Type: Angel
- Location: London, England, United Kingdom
- Relevant deals: 1
- Stages: Seed, Angel, Pre-Seed
- Focus: FinTech, Software, Health Care

William Armitage is the Co-Founder & CFO ,Advisor of The Game Day.

## Brendan O'Driscoll
- Type: Angel
- Location: Los Angeles, California, United States
- Relevant deals: 1
- Stages: Seed, Pre-Seed, Series A
- Focus: Wellness, Health Care, Artificial Intelligence

Brendan O'Driscoll is the Chief Product Officer of KOHO.

## Sidar Sahin
- Type: Angel
- Relevant deals: 1
- Stages: Series A
- Focus: Medical, mHealth, Health Care

Sidar Sahin is Founder & CEO at Peak Games.

## Andrew MacKay
- Type: Angel
- Location: London, England, United Kingdom
- Relevant deals: 1
- Stages: Seed
- Focus: Medical, Hospital, Health Care

Andrew MacKay

## Henry Carleton
- Type: Angel
- Location: London, England, United Kingdom
- Relevant deals: 1
- Stages: Series A
- Focus: Medical, Health Care, Health Diagnostics

Henry is a trained doctor with extensive hospital experience who co-founded Four Eyes Insight to put his talent for finding strategic solutions and planning into helping the NHS.His interest in medical resource management developed during his junior doctor training at Bart’s and the Royal London and he helped trusts tackle the significantchallenges of rotas and the New Deal as Junior Doctors’ Advisor at the London Regional Action Team.Establishing Zircadian Ltd, a software development company focusing on a portfolio of solutions to help NHS organisations plan and organise their medical workforce more strategically and effectively in 2000, he sold it on 11 years later to Allocate with over 140 NHS clients using its products.

## Sachin Agrawal
- Type: Angel
- Relevant deals: 1
- Stages: Series A
- Focus: Medical, Health Care, Health Diagnostics

Sachin Agrawal

## David Prior
- Type: Angel
- Relevant deals: 1
- Stages: Seed
- Focus: Health Care, Medical, Software

David Prior is the former chair of the UK's National Health Service.

## Johnathan Matlock
- Type: Angel
- Location: Bedford, Bedfordshire, United Kingdom
- Relevant deals: 1
- Stages: Seed, Pre-Seed
- Focus: Biotechnology, Medical, Health Care

Johnathan Matlock is Co-Founder Science Angel Syndicate.

## Jim Mellon
- Type: Angel
- Relevant deals: 1
- Stages: Series A, Seed
- Focus: Biotechnology, Health Care, Food and Beverage

Jim Mellon is an international investor with interests in several industries. After leaving Oxford, where he studied PPE, (Philosophy, Politics and Economics) he worked in Asia and the United States for two fund management companies, GT and Thornton, before establishing his own business in 1991. His business operations include two components, alisted fund management company called Charlemagne Capital, and an Asian mining group, Regent Pacific.In addition, Mr. Mellon is Co-Chairman of West African Minerals Corporation and Regent Pacific Group. He is on the board of a number of public quoted companies, including Brazilian Gold Corporation, Charlemagne Capital Limited, Manx Financial Group, Plethora Solutions, Polo Resources, Port Erin Biophara Investments Limited, and the Speymill plc. He is the life tenant of a trust which owns the Burnbrae Group, which has substantial assets in the biotechnology, financial services, property, mining and leisure sectors. Mr. Mellon spends most of his time working on startup ideas and investing. His book, “Wake Up!” was published in 2005; his second book "10 Investments for the Ten Years Ahead" was published in 2008. In 2012, he co-wrote "Cracking the Code" which focuses on the biotechnology sector and how to profit from it. Mr. Mellon lives in the Isle of Man, Brussels and Ibiza and is an honorary fellow of Oriel College, Oxford.

## Brian Kennedy
- Type: Angel
- Relevant deals: 1
- Stages: Angel
- Focus: Music, Medical, Commercial

Brian Kennedy

## Carlos Ballarati
- Type: Angel
- Location: São Paulo, Sao Paulo, Brazil
- Relevant deals: 1
- Stages: Pre-Seed
- Focus: Medical, Database, Consulting

Carlos Ballarati - Founding partner @ Consulta do Bem

## Yusuf Hamied
- Type: Angel
- Location: Mumbai, Maharashtra, India
- Relevant deals: 1
- Stages: Seed
- Focus: Medical, Medical Device

Yusuf Hamied is a Cambridge-educated Chemist and the Non-Executive Chairman of the Board of Directors at Cipla, a large generic pharmaceuticals company founded in 1935 by his father, Khwaja Abdul Hamied. Yusuf became a global celebrity for his role in defying Western multinational pharmaceutical companies in order to provide generic AIDS treatmentsand other drugs to treat poor people in the developing world. After completing his doctorate in 1960, Yusuf joined the family company and vowed to break the dominance of foreign multinationals over the Indian pharmaceutical market by developing cheap generic drugs. Yusuf helped persuade the Indian government to change Indian patent law in 1972, permitting medicines to be copied even if they were under international patent, as long as the process was not the same. The law transformed the Indian pharmaceutical industry, enabling his and other companies to grow by manufacturing generic drugs. In 2001 Yusuf convulsed the global healthcare industry by promising and then delivering a triple drug cocktail, Triomune, that helped fight against HIV and AIDS at prices far lower than those available internationally. Yusuf discusses his subsequent anger when, in 2005, the Indian government brought its patent laws in line with those of the developed world, prohibiting the copying of drugs patented after 1995 without a license and his resentment that he had thereafter “to go with a begging bowl to the multinationals” for licenses. This interview provides not only a personal perspective on how India’s third largest pharmaceutical firm was created, but contributes to the broad debates on the costs and benefits of intellectual property laws, particularly their impact on people who are denied life-saving drugs by their inability to pay for them. Working for Cipla as Managing Director for nearly 52 years, Yusuf was also the 28th richest Indian during one time. ‘CNN-IBN Indian of the year’ and one among the ’25 greatest global living legends’ were the titles that Yusuf won for his reign in the pharma world majorly for making medicines affordable to the poor. Yusuf was awarded with the civil honorary Padma Bhushan from then president APJ Abdul Kalam in the year 2005 for his fight against AIDS, which he often said was going to be as damaging to the society as a massive earthquake would be, if ignored. Yusuf earned his Bachelor's degree (1956), Master's degree (1957) and Ph.D. (1960) in Chemistry from University of Cambridge.

## Brian Souter
- Type: Angel
- Location: Edinburgh, Edinburgh, City of, United Kingdom
- Relevant deals: 1
- Focus: Medical, Commercial, Health Care

Sir Brian Souter is co-founder and Chairman of Stagecoach plc, having retired as Chief Executive in May 2013.Whilst he does not sit with the Souter Investments team in Edinburgh, Sir Brian is active in all investment decision making processes and sits on the boards of our European bus operators (PolskiBus.com and OnniBus.com) and New Zealandtransport group (InMotion).Sir Brian is currently the Vice-President of the Institute of Chartered Accountants of Scotland.

## Anand Mahindra
- Type: Angel
- Location: Mumbai, Maharashtra, India
- Relevant deals: 1
- Stages: Seed, Angel, Series A
- Focus: Education, Artificial Intelligence, Social Media

Graduate, Harvard Univ. and Harvard Business School. Chairman and Managing Director, Mahindra Group. Thought leader in Indian business. Serves on many industry confederations. Initiated the Nanhi Kali programme to provide free education to economically underprivileged girls in India. Co-Founder, Naandi Danone, India's largest safe drinkingwater provider to rural areas. Life Trustee, Board of Naandi Foundation, which provides meals to 1.3 million children daily. Co-Chair, World Economic Forum Annual Meeting 2009. Named among World’s 50 Greatest Leaders, Fortune Magazine (2014); named one of the top 25 most powerful business people in Asia, Fortune Magazine (2011).

## Inaki Berenguer
- Type: Angel
- Location: New York, New York, United States
- Relevant deals: 1
- Stages: Seed, Angel, Pre-Seed
- Focus: Financial Services, FinTech, E-Commerce

Inaki Berenguer is the President and Co-founder at iPronics Programmable Photonics.

## Alex Macdonald
- Type: Angel
- Location: London, England, United Kingdom
- Relevant deals: 1
- Stages: Pre-Seed, Seed, Series A
- Focus: Software, Artificial Intelligence, FinTech

Alex Macdonald is the Co-Founder and CEO of sequel - an investment platform on a mission to help athletes build a legacy for their families and the world. He previously Co-Founded Velocity Black, raised more than $40m in funding, and which was successfully exited to US Bank Capital One in 2023. He is a serial angel investor having invested in 50early stage startups and funds.

## Charlotte Scott
- Type: Angel
- Relevant deals: 1
- Stages: Seed
- Focus: Medical, Health Care, Pharmaceutical

Charlotte Scott

## Phil Kirby
- Type: Angel
- Location: Crewe, Cheshire East, United Kingdom
- Relevant deals: 1
- Stages: Seed
- Focus: Medical, Hospital, Medical Device

Phil founded Health Intelligence in 1996 and maintains a vital role in the company shaping strategy and innovation. After graduating from Keele with an MBA on the Health Executive Programme, Phil spent thirteen years in the NHS as a senior manager responsible for I.T., registration and screening functions. This experience from within the NHS andprivate sector has given him an in-depth understanding of how cross sector population-based solutions can help the NHS overcome key challenges.

## Robert Marshall
- Type: Angel
- Location: Cambridge, Cambridgeshire, United Kingdom
- Relevant deals: 1
- Stages: Seed
- Focus: Medical, Health Care, Medical Device

Robert Marshall is Executive Chairman of Martlet Capital.

## Simon Franks
- Type: Angel
- Location: London, England, United Kingdom
- Relevant deals: 1
- Stages: Seed, Pre-Seed, Series A
- Focus: FinTech, Health Care, Payments

Simon Franks is the founder and managing partner of Redbus Ventures and Chairman of the Franks Family Foundation. (www.thefff.org)

## Jag Singh
- Type: Angel
- Location: Berlin, Berlin, Germany
- Relevant deals: 1
- Stages: Pre-Seed, Seed, Angel
- Focus: Software, FinTech, Artificial Intelligence

Jag is one of Europe's most active angel investors, and is a Managing Partner at Angel Invest Ventures in Berlin. He's founded several companies (including two exits and a spectacular failure), and invested in over 100 startups over the last six years, including Spire (SPAC), Nutmeg (exit to JPM), Disperse, Eversend, Restack, and Anytype.He’s an ad-man at heart, and spent over a decade as a political strategist advising high-profile politicians, campaigns and corporations across the US and Europe. Jag is fluent in six languages, and can be found on Twitter via @JagSingh

## Ian Noel
- Type: Angel
- Location: Madrid, Madrid, Spain
- Relevant deals: 1
- Stages: Seed, Series A
- Focus: Pet, Education, Film

Ian Noel - Angel & Growth Investor @ Lingokids

## Andrew Fisher
- Type: Angel
- Location: Brighton, East Sussex, United Kingdom
- Relevant deals: 1
- Stages: Series A
- Focus: Medical, Life Science, Biotechnology

As an Executive Vice President at Wesley Clover, Andrew currently manages a portfolio of ICT and Digital Media companies globally. In addition he also acts as a business prime for the Wesley Clover affiliate program.Andrew connects teams of new graduates with tier one Network Operator, Service Provider and Communications EquipmentManufactures globally. These partnerships provide invaluable customer insight and a route to market for each of the Affiliates. Through these partnerships, each party realizes time to revenue, time to market and engine for innovation advantage.Andrew serves on the Board of Directors for March Entertainment, Benbria and Teldio Corporations. He is also a member of the Advisory board for the Canadian Digital Media Network and the Canadian Department of Foreign Affairs and International Trade Information and Communications Technologies.Andrew is an honors graduate from the University of British Columbia, with an academic background in Computer Science, Engineering and Economics.

## Tim Davis
- Type: Angel
- Location: Santa Monica, California, United States
- Relevant deals: 1
- Stages: Series A, Series B, Seed
- Focus: Health Care, Biotechnology, Medical

Timothy T Davis, MD is Board Certified in Physical Medicine and Rehabilitation (Physiatry) and Pain Medicine. The founder of Source Healthcare, Source Surgery Center, Alpha Diagnostics and he is an expert in spine and musculoskeletal disorders as well as interventional pain management to treat neck, back and sports injuries. Dr. Davis hasperformed extensive clinical research using biological therapies such as stem cells and other biologics for spine and joint injuries.
He has consulted and invested in SaaS, medical device, biologics, cannabis, and psychedelics sectors.

## Justin Mateen
- Type: Angel
- Location: Los Angeles, California, United States
- Relevant deals: 1
- Stages: Seed, Series A, Pre-Seed
- Focus: Software, E-Commerce, Health Care

Justin Mateen is the Cofounder and former CMO of Tinder, the world's largest dating platform. In 2021, and 2022 Business Insider ranked Mateen as the best early stage investor in the US, placing him at the number 1 spot on the top 100 list of US Seed Investors both years. In 2020, Forbes included Mateen on their list of the decade's top10 tech entrepreneurs. Fast Company has listed him as one of the most creative people in business.Founded in 2012, Tinder is the highest grossing app on Apple's app store since 2017 and was valued at over $40 Billion dollars in 2021.

## Julien Codorniou
- Type: Angel
- Location: London, England, United Kingdom
- Relevant deals: 1
- Stages: Seed, Series A, Pre-Seed
- Focus: Software, E-Commerce, Apps

Julien is an investor at Felix Capital where he focuses on SaaS (Worktech in particular) and gaming investments.Before joining Felix, Julien Codorniou spent 11 years at Facebook where he led the global platform partnerships team, helping Facebook partners to build, grow and monetize their mobile apps and games. From 2016 to 2021, he has beenserving as Vice President of Workplace. Under his leadership, Workplace went from 0 to 9 million paid subscribers at companies like Walmart, Grab, GSK, Nestlé, Chevron, MercadoLibre, ServiceNow, Astrazeneca, Lixil, Spotify, Save the Children and many more globally. Julien started his career in finance and before Facebook he was Director of Business Development at Microsoft Corp.Since 2012, Julien has served on the board of the French media group Le Monde. He is the co-author of the book: "The Kelkoo.com success story"published by Pearson in 2005.His former investments, as business angel include companies like TripleDot Studios, Bloom & Wild, Pigment, Xentral, Homesome, Olio, Peanut, Nabla, Curio, Linktree, Airlift Technologies and Sunday.He grew up in France and now lives in London with his wife and their two boys.

## Martin Varsavsky
- Type: Angel
- Location: Madrid, Madrid, Spain
- Relevant deals: 1
- Stages: Seed, Series A, Angel
- Focus: Health Care, Social Media, Software

Martin Varsavsky is the Founder and Chairman of Gameto. He previously worked at Fon as a Chairman. Martin Varsavsky attended Columbia Business School.

## Nicholas Edwards
- Type: Angel
- Location: Oxford, Oxfordshire, United Kingdom
- Relevant deals: 1
- Stages: Seed
- Focus: Medical, Health Care, Life Science

Nick serves as the Chairman of Prescient’s Board of Directors. He holds a degree in physiological sciences from The Queen’s College, University of Oxford, and completed his training in clinical medicine (BM, BCh) at Green College (now Green Templeton College), University of Oxford. Nick practiced in the areas of cardiology and general surgerybefore joining Andersen Consulting (now known as Accenture), eventually becoming the global leader of Accenture’s pharmaceutical R&D business during his 18-year tenure. In 2005, he founded Kinapse to provide consulting and outsourcing services to the pharmaceutical industry. Nick served as Kinapse’s Chairman until the company was sold to HgCapital in early 2016.

## Jim Breyer
- Type: Angel
- Location: Menlo Park, California, United States
- Relevant deals: 1
- Stages: Series B, Series A, Seed
- Focus: Artificial Intelligence, Health Care, Information Technology

Jim Breyer is based out of Austin, Texas, and is the Founder & CEO of Breyer Capital. Jim previously worked at IDG Capital as Co-Chairman. Jim Breyer attended Harvard Business School.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co